Cool Company Raises · $68.4M · integratedbio.com
Integrated Biosciences raises a $68.4M round
Integrated Biosciences is a biotechnology company specializing in synthetic biology and machine learning to develop advanced therapeutics for age-related diseases. Founded in 2022, the company focuses on innovative drug discovery methods, utilizing AI and synthetic biology to increase efficiency in drug development. Its cutting-edge approach allows for the identification and modulation of biological pathways, alongside the discovery of novel small-molecule drug candidates. The company's mission is to achieve healthier human aging through scientific advancements.
Visit sourceGet the next one by email
One brief each weekday morning. One-click unsubscribe.